The Efficacy of Thrombin-Gelatin Matrix in Hemostasis for Large Breast Tumor after Vacuum-Assisted Breast Biopsy
Abstract
:1. Introduction
2. Materials and Methods
2.1. Patients
2.2. Exclusion
2.3. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Lee, S.H.; Kim, E.K.; Kim, M.J.; Moon, H.J.; Yoon, J.H. Vacuum-assisted breast biopsy under ultrasonographic guidance: Analysis of a 10-year experience. Ultrasonography 2014, 33, 259–266. [Google Scholar] [CrossRef] [PubMed]
- Simon, J.R.; Kalbhen, C.L.; Cooper, R.A.; Flisak, M.E. Accuracy and Complication Rates of US-guided Vacuum-assisted Core Breast Biopsy: Initial Results. Radiology 2000, 215, 694–697. [Google Scholar] [CrossRef] [PubMed]
- Park, H.L.; Hong, J. Vacuum-assisted breast biopsy for breast cancer. Gland Surg. 2014, 3, 120–127. [Google Scholar] [CrossRef] [PubMed]
- Krishnan, S.; Conner, T.M.; Leslie, R.; Stemkowski, S.; Shander, A. Choice of hemostatic agent and hospital length of stay in cardiovascular surgery. Semin. Cardiothorac. Vasc. Anesth. 2009, 13, 225–230. [Google Scholar] [CrossRef] [PubMed]
- Kim, H.J.; Fraser, M.R.; Kahn, B.; Lyman, S.; Figgie, M.P. The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: A randomized controlled trial. J. Bone Jt. Surg. Am. 2012, 94, 1160–1165. [Google Scholar] [CrossRef] [PubMed]
- Echave, M.; Oyaguez, I.; Casado, M.A. Use of Floseal®, a human gelatine-thrombin matrix sealant, in surgery: A systematic review. BMC Surg. 2014, 14, 111. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zheng, J.; Cai, S.; Song, H.; Wang, Y.; Han, X.; Han, G.; Wu, H.; Gao, Z. Prediction of postoperative hematoma occurrence after ultrasound-guided vacuum-assisted breast biopsy in minimally invasive surgery for percutaneous removal of benign breast lesions. Gland Surg. 2020, 9, 1346–1353. [Google Scholar] [CrossRef] [PubMed]
- Huo, H.P.; Wan, W.B.; Wang, Z.L.; Li, H.F.; Li, J.L. Percutaneous Removal of Benign Breast Lesions with an Ultrasound-guided Vacuum-assisted System: Influence Factors in the Hematoma Formation. Chin. Med. Sci. J. 2016, 31, 31–36. [Google Scholar] [CrossRef]
- Jung, H.K.; Moon, H.J.; Kim, M.J.; Kim, E.K. Benign core biopsy of probably benign breast lesions 2 cm or larger: Correlation with excisional biopsy and long-term follow-up. Ultrasonography 2014, 33, 200–205. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Eller, A.; Janka, R.; Lux, M.; Saake, M.; Schulz-Wendtland, R.; Uder, M.; Wenkel, E. Stereotactic vacuum-assisted breast biopsy (VABB)—A patients’ survey. Anticancer Res. 2014, 34, 3831–3837. [Google Scholar] [PubMed]
- Lian, Z.Q.; Yu, H.Y.; Zhang, A.Q.; Xie, S.M.; Wang, Q. Use of urinary balloon catheter to prevent postoperative bleeding after ultrasound-guided vacuum-assisted breast biopsy. Breast J. 2020, 26, 144–148. [Google Scholar] [CrossRef] [PubMed]
- Fu, S.M.; Wang, X.M.; Yin, C.Y.; Song, H. Effectiveness of hemostasis with Foley catheter after vacuum-assisted breast biopsy. J. Thorac. Dis. 2015, 7, 1213–1220. [Google Scholar] [CrossRef] [PubMed]
- Schaefer, F.K.; Order, B.M.; Eckmann-Scholz, C.; Strauss, A.; Hilpert, F.; Kroj, K.; Biernath-Wupping, J.; Heller, M.; Jonat, W.; Schaefer, P.J. Interventional bleeding, hematoma and scar-formation after vacuum-biopsy under stereotactic guidance: Mammotome(®)-system 11 g/8 g vs. ATEC(®)-system 12 g/9 g. Eur. J. Radiol. 2012, 81, e739–e745. [Google Scholar] [CrossRef] [PubMed]
- Henkel, A.; Cooper, R.A.; Ward, K.A.; Bova, D.; Yao, K. Malignant-appearing microcalcifications at the lumpectomy site with the use of FloSeal hemostatic sealant. AJR Am. J. Roentgenol. 2008, 191, 1371–1373. [Google Scholar] [CrossRef] [PubMed]
- Heil, J.; Schaefgen, B.; Sinn, P.; Richter, H.; Harcos, A.; Gomez, C.; Stieber, A.; Hennigs, A.; Rauch, G.; Schuetz, F.; et al. Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy? Eur. J. Cancer 2016, 69, 142–150. [Google Scholar] [CrossRef] [PubMed]
- Heil, J.; Kummel, S.; Schaefgen, B.; Paepke, S.; Thomssen, C.; Rauch, G.; Ataseven, B.; Grosse, R.; Dreesmann, V.; Kuhn, T.; et al. Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques. Br. J. Cancer 2015, 113, 1565–1570. [Google Scholar] [CrossRef] [PubMed]
- He, X.F.; Ye, F.; Wen, J.H.; Li, S.J.; Huang, X.J.; Xiao, X.S.; Xie, X.M. High Residual Tumor Rate for Early Breast Cancer Patients Receiving Vacuum-assisted Breast Biopsy. J. Cancer 2017, 8, 490–496. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- de Quintana-Schmidt, C.; Leidinger, A.; Teixido, J.M.; Bertran, G.C. Application of a Thrombin-Gelatin Matrix in the Management of Intractable Hemorrhage During Stereotactic Biopsy. World Neurosurg. 2019, 121, 180–185. [Google Scholar] [CrossRef] [PubMed]
- Waldert, M.; Remzi, M.; Klatte, T.; Klingler, H.C. FloSeal reduces the incidence of lymphoceles after lymphadenectomies in laparoscopic and robot-assisted extraperitoneal radical prostatectomy. J. Endourol. 2011, 25, 969–973. [Google Scholar] [CrossRef] [PubMed]
Characteristics | All Patients (n = 147) | All Lesion (n = 206) | Hemostasis with TGM (n = 72) | Hemostasis without TGM (n = 75) | p Value |
---|---|---|---|---|---|
Age | 39 (17–78) | 38 (14–68) | 0.6 | ||
Size (cm) | 2 (2–5) | 2 (2–4.6) | 0.42 | ||
Lesion number | 1.0 | ||||
Single | 102 (69.4%) | 50 (69.4%) | 52 (69.3%) | ||
Multiple | 45 (30.6%) | 22 (30.6%) | 23 (30.7%) | ||
Pathology | 1.0 | ||||
Benign | 202 (98.1%) | 100 | 102 | ||
Malignant | 4 (1.9%) | 2 | 2 |
Complications | Hemostasis with TGM (n = 72) | Hemostasis without TGM (n = 75) | p Value |
---|---|---|---|
Post-VABB hematoma | 0.85 | ||
Yes | 18 (25.0%) | 20 (26.7%) | |
No | 54 (75.0%) | 55 (73.3%) | |
Acute bleeding | 0.003 | ||
Yes | 4 (5.5%) | 17 (22.7%) | |
No | 68 (94.4%) | 58 (77.3%) |
Parameters | Odds Ratio | 95% CI | p Value |
---|---|---|---|
Lesion number (single/>2) | 1.109 | 0.493–2.497 | 0.802 |
Lesion size (2/> 2 cm) | 0.783 | 0.373–1.644 | 0.518 |
Thrombin-gelatin matrix (No/Yes) | 1.108 | 0.528–2.327 | 0.787 |
Parameters | Odds Ratio | 95% CI | p Value |
---|---|---|---|
Lesion number (single/>2) | 1.557 | 0.514–4.711 | 0.434 |
Lesion size (2/> 2 cm) | 0.64 | 0.244–1.678 | 0.364 |
Thrombin-gelatin matrix (No/Yes) | 5.225 | 1.648–16.57 | 0.005 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tzeng, Y.-D.T.; Liu, S.-I.; Wang, B.-W.; Chen, Y.-C.; Chang, P.-M.; Chen, I.-S.; Sheu, J.J.-C.; Hsiao, J.-H. The Efficacy of Thrombin-Gelatin Matrix in Hemostasis for Large Breast Tumor after Vacuum-Assisted Breast Biopsy. J. Pers. Med. 2022, 12, 301. https://doi.org/10.3390/jpm12020301
Tzeng Y-DT, Liu S-I, Wang B-W, Chen Y-C, Chang P-M, Chen I-S, Sheu JJ-C, Hsiao J-H. The Efficacy of Thrombin-Gelatin Matrix in Hemostasis for Large Breast Tumor after Vacuum-Assisted Breast Biopsy. Journal of Personalized Medicine. 2022; 12(2):301. https://doi.org/10.3390/jpm12020301
Chicago/Turabian StyleTzeng, Yen-Dun Tony, Shiuh-Inn Liu, Being-Whey Wang, Yu-Chia Chen, Po-Ming Chang, I-Shu Chen, Jim Jinn-Chyuan Sheu, and Jui-Hu Hsiao. 2022. "The Efficacy of Thrombin-Gelatin Matrix in Hemostasis for Large Breast Tumor after Vacuum-Assisted Breast Biopsy" Journal of Personalized Medicine 12, no. 2: 301. https://doi.org/10.3390/jpm12020301